(Alliance News) - EDX Medical Group PLC on Monday said it has signed an agreement with Spire Healthcare Group PLC to explore opportunities to utilise new diagnostic products and patient testing services.
EDX Medical is a Cambridge, England-based firm the develops digital diagnostic products and services to treat cancer, heart disease, and infectious diseases. Spire Healthcare is a London-based healthcare company.
The two firms signed a memorandum of understanding that includes the promotion of each other's existing and future clinical products and services, establishing patient referral and treatment pathways, developing joint healthcare and wellbeing propositions, and providing services to support the delivery of "world class independent healthcare" in the UK.
"Spire Healthcare is an outstanding healthcare leader and we at EDX Medical are delighted to sign this agreement which paves the way for us to work together to further improve the delivery of innovative diagnostics and class-leading personalised medicine for patients," said EDX Medical Founder & Chief Scientific Officer Chris Evans.
"Relationships with leading hospital groups and clinics are an important element of our strategy to develop and supply the most advanced tests and supporting services available to treat major diseases."
Shares in EDX Medical Group were up 4.2% at 12.50 pence each on the Aquis Exchange on Monday afternoon. Spire Healthcare shares were up 1.0% at 210.50 pence each in London.
By Emily Parsons, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.


(Alliance News) - The FTSE 100 closed higher on Thursday as ongoing political uncertainty was offset by encouraging UK GDP data, a cooling oil price a...




(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.